Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:21506603rdf:typepubmed:Citationlld:pubmed
pubmed-article:21506603lifeskim:mentionsumls-concept:C1049019lld:lifeskim
pubmed-article:21506603lifeskim:mentionsumls-concept:C0001128lld:lifeskim
pubmed-article:21506603lifeskim:mentionsumls-concept:C0030946lld:lifeskim
pubmed-article:21506603lifeskim:mentionsumls-concept:C0063856lld:lifeskim
pubmed-article:21506603lifeskim:mentionsumls-concept:C0021469lld:lifeskim
pubmed-article:21506603lifeskim:mentionsumls-concept:C0243072lld:lifeskim
pubmed-article:21506603pubmed:issue5lld:pubmed
pubmed-article:21506603pubmed:dateCreated2011-5-27lld:pubmed
pubmed-article:21506603pubmed:abstractTextFour new compounds were isolated from the methanol extract of the aerial parts of Anarrhinum orientale: 6'-O-cinnamoylmussaenosidic acid (1), 6'-O-cinnamoyl-8-O-(6'''-O-cinnamoylglucopyranosyl)mussaenosidic acid (2), (2E,6E)-8-{[(2E,6E)-8-hydroxy-2,6-dimethylocta-2,6-dienoyl]oxy}-2,6-dimethylocta-2,6-dienoic acid (3), and (2E,6E)-8-{[(2E,6E)-8-acetoxy-2,6-dimethylocta-2,6-dienoyl]oxy}-2,6-dimethylocta-2,6-dienoic acid (4). The known 8-O-cinnamoylmussaenosidic acid (5) was also identified. All five compounds were tested for inhibition of the hepatitis C virus (HCV) protease. Compounds 1 and 5 exhibited moderate activity, while 2 and 3 showed weak effects. No inhibitory activity on the human serine protease was observed for any of these compounds, which may infer the selectivity toward the viral protease. A computational docking study of the isolated compounds against HCV protease was used to formulate a hypothetical mechanism for the inhibitory activity of the active compounds on the enzymes tested.lld:pubmed
pubmed-article:21506603pubmed:languageenglld:pubmed
pubmed-article:21506603pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21506603pubmed:citationSubsetIMlld:pubmed
pubmed-article:21506603pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21506603pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21506603pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21506603pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21506603pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21506603pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21506603pubmed:statusMEDLINElld:pubmed
pubmed-article:21506603pubmed:monthMaylld:pubmed
pubmed-article:21506603pubmed:issn1520-6025lld:pubmed
pubmed-article:21506603pubmed:authorpubmed-author:HattoriMasaoMlld:pubmed
pubmed-article:21506603pubmed:authorpubmed-author:Abdel-SattarE...lld:pubmed
pubmed-article:21506603pubmed:authorpubmed-author:El-HalawanyAl...lld:pubmed
pubmed-article:21506603pubmed:authorpubmed-author:Salah El...lld:pubmed
pubmed-article:21506603pubmed:authorpubmed-author:Abdel...lld:pubmed
pubmed-article:21506603pubmed:issnTypeElectroniclld:pubmed
pubmed-article:21506603pubmed:day27lld:pubmed
pubmed-article:21506603pubmed:volume74lld:pubmed
pubmed-article:21506603pubmed:ownerNLMlld:pubmed
pubmed-article:21506603pubmed:authorsCompleteYlld:pubmed
pubmed-article:21506603pubmed:pagination943-8lld:pubmed
pubmed-article:21506603pubmed:meshHeadingpubmed-meshheading:21506603...lld:pubmed
pubmed-article:21506603pubmed:meshHeadingpubmed-meshheading:21506603...lld:pubmed
pubmed-article:21506603pubmed:meshHeadingpubmed-meshheading:21506603...lld:pubmed
pubmed-article:21506603pubmed:meshHeadingpubmed-meshheading:21506603...lld:pubmed
pubmed-article:21506603pubmed:meshHeadingpubmed-meshheading:21506603...lld:pubmed
pubmed-article:21506603pubmed:meshHeadingpubmed-meshheading:21506603...lld:pubmed
pubmed-article:21506603pubmed:meshHeadingpubmed-meshheading:21506603...lld:pubmed
pubmed-article:21506603pubmed:meshHeadingpubmed-meshheading:21506603...lld:pubmed
pubmed-article:21506603pubmed:meshHeadingpubmed-meshheading:21506603...lld:pubmed
pubmed-article:21506603pubmed:meshHeadingpubmed-meshheading:21506603...lld:pubmed
pubmed-article:21506603pubmed:meshHeadingpubmed-meshheading:21506603...lld:pubmed
pubmed-article:21506603pubmed:year2011lld:pubmed
pubmed-article:21506603pubmed:articleTitleHCV-NS3/4A protease inhibitory iridoid glucosides and dimeric foliamenthoic acid derivatives from Anarrhinum orientale.lld:pubmed
pubmed-article:21506603pubmed:affiliationDepartment of Pharmacognosy, Faculty of Pharmacy, Cairo University, Cairo 11562, Egypt.lld:pubmed
pubmed-article:21506603pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...http://linkedlifedata.com/r...pubmed-article:21506603lld:chembl